adult treatment panel (ATP) scores, coronary heart disease, electrocardiography, Framingham risk score, left ventricular hypertrophy s u m m a r y Background: Surface electrocardiography (ECG) for assessing the estimated risk for future coronary heart diseases in the asymptomatic population has not been fully explored. Furthermore, information regarding age-related differences in such a clinical issue is lacking. Methods: We evaluated the diagnostic performance of several combinations of voltage criteria obtained from electrocardiography by comparison to echocardiography performed on 379 individuals without preexisting cardiovascular diseases and determined the association of these criteria with the Framingham risk (FRS) and the adult treatment panel (ATP) scores from the National Cholesterol Education Program. Results: The ECG parameters were significantly correlated with the participants' age. Among participants < 65 years of age, several criteria (including the Sokolow-Lyon score, Cornell voltage, Cornell product, McPhie score and Gubner & Ungerleider criteria) were positively associated with FRS by multivariate analysis, while Cornell voltage, Cornell product, Gubner & Ungerleider criterion and QRS duration were significantly associated with the ATP score. Few ECG criteria were associated with both cardiovascular risk scores above 65 years of age. However, gender-adjusted McPhie and Gubner & Ungerleider criterion were observed to be powerful predictors of left ventricular hypertrophy (LVH) in subjects less than 65 years old, as determined by echocardiography. Conclusion: Electrical alterations, as determined by various parameters from surface ECG, correlate with age and estimated cardiovascular risk factors, while McPhie and Gubner & Ungerleider criteria help identify structural changes in terms of LVH in subjects of a relatively younger age.
Introduction
Much effort has been focused over the decades on developing tools to assess the risk for coronary heart disease (CHD) in the asymptomatic population. The Framingham risk score (FRS), which incorporates risk factors determined during the Framingham Heart Study, was one of the first algorithms developed for this purpose 1 .
The parameters of the FRS were later extended to include family history, diabetes, and metabolic syndrome in the adult treatment panel (ATP) scores developed by the NCEP III 2 .
A clinical finding that predicts a high rate of cardiovascular events is left ventricular hypertrophy (LVH). The physical modifications associated with LVH can be detected readily by echocardiography 3 . However, cost and technical considerations have limited the use of echocardiography for large-scale screening applications 4 . Electrocardiology provides information about the electrical properties of the myocardium 5 , and ECG parameters have been shown to be indicators of LVH in patients with hypertension 6e8 .
Although the various criteria are highly specific for LVH, they are limited by low sensitivity. The commonly used ECG abnormalities q All contributing authors declare no conflict of interest. include signs of left atrial abnormality and voltage criteria after Sokolow-Lyon and Cornell. The sensitivity of ECG in detecting LVH determined by echocardiography has been reported to be 15% after Sokolow-Lyon, 15% after McPhie and 31% using all the criteria combined in a previous study 9 . However, the relationship between surface ECG and validated cardiovascular events, when assessed by FRS or metabolic (ATP) scores, has not been fully elucidated. To further investigate the use of electrocardiography for screening populations for assessing future projected cardiovascular diseases, we examined the diagnostic performance of several new combinations of voltage criteria and their association with the FRS and ATP scores.
Methods

Study population
Four hundred individuals who underwent general health evaluations were considered for enrollment during the study period (from 2006 to 2008); however, 21 individuals with known cardiovascular diseases, which was the only criterion for exclusion, were excluded from this study. The data for the remaining 379 participants (mean age ¼ 55.6 AE 11.05 years; proportion of women ¼ 41.2%) were analyzed. Among the 379 participants, the prevalence of hypertension and diabetes were 13.5% and 6.9%, respectively. Parameters derived from 12-lead surface ECG, anthropometrics, clinical variables, medical history, and the results of echocardiography were recorded. The local institutional ethics board proved this study.
Measures of cardiovascular risk
Two different estimates of cardiovascular risk were used in the evaluation: the FRS 1 and the ATP score calculated according to NCEP III 2 .
Electrocardiography
Participants underwent routine 12-lead surface electrocardiography (ECG) examination with recordings obtained using autonomic instruments (Page Writer Trim III, Philips, Andover, MA, USA) stored for further analysis. Electrocardiographic criteria evaluated in this study included: (1) Sokolow-Lyon voltage: SV 1 þ RV 5 or RV 6 > 3.5 mV 10 ; (2) gender-adjusted Cornell voltage criteria: SV 3 þ RaVL > 2.8 mV for men and > 2.0 mV for women 11 ;
(3) Cornell product: (SV 3 þ RaVL) Â QRS duration > 244 mV; 
Echocardiography
Transthoracic echocardiography was performed by a single experienced technician using a Hewlett Packard instrument (Sonos 5500 series) equipped with a 2.5e4.5 MHz transducer. Parameters including left atrium (LA) diameter, left ventricular (LV) enddiastolic (EDV), end-systolic (ESV) volume, and ejection fraction (EF) by the modified Teichholz method with subsequent LV mass determination from M-mode were all measured as routine. LV mass index (g/m 2 ) was defined as the ratio of LV mass to body surface area (BSA). LV mass index larger than 95 gm/m 2 in women and 115 gm/m 2 in men was further defined as LV hypertrophy (LVH). All parameters were assessed by M-mode from the para-sternal longaxis view. Patients with at least significant valvular heart disease, pulmonary hypertension (systolic pulmonary arterial pressure more than 65 mmHg), existence of congenital heart diseases, or LV systolic dysfunction, were excluded from this study.
Statistical analysis
Relationships between morphologic alteration by ECG criteria and age were assessed using Pearson's (for continuous variables) and point biserial (for categorical variables with two levels) correlation coefficients. The nonparametric trend test was used to test the trend of various electrical components across different age groups. Linear regression analysis was performed to assess the ECG parameters influencing FRS and ATP scores; BMI and gender were entered into FRS, and age and gender were entered into ATP score in multivariate models. Logistics regression analysis was performed to analyze the odds ratio of significant factors associated with patients with LVH. Variables with p < 0.05 in the univariate analysis were selected and evaluated by multivariate regression models. Statistical analyses were performed using SPSS 15.0 statistical software (SPSS Inc, Chicago, IL, USA). Furthermore, a receiver operating characteristic (ROC) curve was employed to obtain the area under the curve (AUC) in identifying LVH by utilizing all ECGderived parameters STATA 8.0 (StataCorp, College Station, TX, USA). All statistical assessments were two-sided and considered significant when p < 0.01.
Results
The echocardiographically defined LVH geometries are shown schematically in Fig. 1 for participants stratified by age. Among the participants younger than 65 years of age, 71.2% (220/309) had normal results and 23.3% (72/309) showed concentric remodeling. Among the participants older than 65 years of age, the fraction with concentric remodeling was the same as that in the younger patients, but the fractions of patients with eccentric remodeling and concentric hypertrophy were greater, and the fraction with normal results decreased to 45.6%.
In Table 1 , we listed the baseline demographic data enrolled in this study. With increasing age, body height tended to decrease with increasing waist circumference, waist-to-hip ratio, systolic blood pressure, body mass index and decreased body surface area (trend p < 0.001) observed. There was also a trend toward higher fasting serum glucose, total cholesterol, triglyceride and worsened renal function (trend p < 0.001) with aging. Prevalence of hypertension and diabetes history increased with age together with lower prevalence of smoking (trend p < 0.05). Echo-derived parameters including higher LV mass, mass index and left atrial diameter, also increased with aging, as well as increasing estimated cardiovascular risk scores (all p < 0.05).
The relationships between age and various ECG parameters are shown in Table 2 . The QRS axis showed a significant negative correlation with age (g ¼ À0.112, p ¼ 0.031). In contrast, there were positive correlations between age and ECG-derived P duration, QRS axis, QTc, ATP score, FRS, left atrial enlargement (LAE), strain pattern, Sokolow-Lyon score, Cornell voltage (gender adjusted), Cornell product, McPhie score, and Gubner & Ungerleider criterion (p < 0.05).
Univariate and multivariate linear regression analyses were performed to examine the relationship between the FRS and ECG parameters ( (Table 3 ). Among the participants who were 65 years of age or older, only the Cornell product was significantly associated with FRS by univariate analysis, and this association disappeared after multivariate analysis.
The Gubner & Ungerleider criterion was positively associated with ATP score after adjustment for age and gender among participants younger than 65 years of age (p < 0.05) (Table 4 ).
However, there were no significant relationships found between any of the ECG parameters and ATP score among participants 65 years of age or older.
The univariate logistic regression model indicated that the following parameters were significantly correlated with LVH among subjects who were younger than 65 years of age ( 
Assessment of Cardiovascular-Related Risks by Surface Electrocardiography
The ROC curve, calculated by using all ECG-based criteria in identifying echo-defined LVH for all participants who were younger than 65 years of age, generally gave a better AUC while compared with those older than 65 years of age ( Fig. 2) , with the genderadjusted Cornell and Cornell Product yielding the largest AUC of 0.75 and 0.77 in participants aged less than 65 years and 0.65 and 0.64 in participants aged more than 65 years, respectively. With appropriately selected cut-off, the sensitivities and specificities in diagnosing LVH by utilizing Sokolow-Lyon score, gender-adjusted Cornell voltage, McPhie score, Gubner & Ungerleider criterion and Cornell product in subjects less than 65 years old were 64.7%, 76.5%, 70.6%, 64.7%, and 82.4%, 72.3%, 73.3%, 63%, 73.6%, and 76%, respectively. In those aged more than 65 years, the sensitivities and specificities in diagnosing LVH were 47.6%, 66.7%, 57.1%, 52.4%, and 71.4% and 43.5%, 63%, 43.5%, 56.5%, and 56.5%, respectively.
Discussion
In this study, we evaluated the relationships between various ECG parameters, age, and estimates of cardiovascular risk and the different diagnostic yields among subjects of different age groups. We further tested the usefulness and age-related differences of surface ECG in identifying the presence of LVH determined by echocardiography. We observed that the ECG parameters were significantly correlated with the participant's age and that several ECG parameters were positively correlated with estimated cardiovascular risks as assessed by FRS and ATP with and without adjustment.
There has been much effort over the decades on developing tools to assess the risk for CHD in the asymptomatic population. Because of the complexity of CHD and its multiple causes, it is now generally accepted that an algorithm for accurately predicting the presence of CHD will comprise multiple parameters. The FRS, which incorporates risk factors determined during the Framingham study, was one of the first such algorithms 1 . The ATP III score developed by the NCEP III, extended the Framingham parameters by including family history, diabetes, and metabolic syndrome and defining the risk in terms of 3 categories on the basis of the probability of experiencing a cardiac event over a 10 year period 2 . The FRS and the NCEP III recommendations are still considered to be very useful in assessing cardiovascular risk in asymptomatic individuals 15 . ECG remains one of the most widely available and least expensive diagnostic tools potentially appropriate for screening large populations for cardiovascular disease. A unique aspect of our study was that we examined the association of the ECG parameters with the two major tools, the FRS and ATP scores, for estimating cardiovascular risk. Among the younger participants, multivariate linear regression analysis showed that several ECG parameters were all positively, significantly associated with FRS and ATP scores which remained statistically significant after multivariate adjustment.
Numerous investigators have attempted to identify criteria for ECG diagnosis of LVH 12,16e18 . The various criteria are highly specific for LVH but are limited by low sensitivity. In comparison with echocardiography, which found a 20% prevalence of LVH in the Framingham Heart Study 19 , ECG found a prevalence of only 2% 16 . Echocardiographic analysis is an excellent tool for determining the mass and shape of the heart, and because LV mass has become the "gold standard" clinical measure of LVH 20 , most evaluations of the diagnostic performance of ECG have measured it against echocardiography. The four ECG parameters in our study that were associated with the FRS among the younger group of participants were also associated with the presence of LVH after univariate analysis. However, only the McPhie score and the Gubner & Ungerleider criterion remained significant predictors of the presence of LVH after multivariate analysis. The individual ECG criteria that have been evaluated in previous reports 13, 17, 21 , have demonstrated specificities in the range of 90% to 97%, whereas sensitivities have been significantly lower, ranging from 3.8% to a maximum of 38% in patients with less severe hypertrophy (LV mass index [LVMI] 152.8 g/m 2 to 62% in patients with LVMI > 152.8 g/m 2 ). Whether parameters can be identified that will allow ECG to substitute for echocardiography as a screening tool is an unlikely 20 . Nevertheless, the use of ECG voltage criteria can be a valuable tool to assist in the challenge of diagnosing CHD in asymptomatic individuals. The use of ECG voltage criteria has recently been successfully extended to the detection of disorders such as hypertrophic cardiomyopathy in young people 22 . In this application, the reported positive predictive value (PPV) and negative predictive value (NPV) for the Gubner & Ungerleider criterion were 100% and 93%, respectively, and combination with the Cornell voltage improved the NPV. Kohsaka et al. demonstrated that the Cornell voltage criterion was a predictor of ischemic stroke and that, when combined with echocardiographic analysis, it was associated with a 3.5-fold increase in risk for stroke 23 . Morin et al have shown that QRS duration predicted sudden cardiac death in patients with hypertension 24 . A study by Palmieri et al has revealed an association of ECG characteristics and metabolic risk factors with inappropriately high LV mass in patients with LVH 25 . In our study, several ECG parameters were helpful and yielded useful diagnostic accuracy in identifying LVH in the younger rather than the older population. Furthermore, our data revealed that even in a relatively healthy population free from known cardiovascular diseases, the electrical remodeling patterns in terms of various surface ECG parameters were observed to parallel with the aging process. In our data, several specific ECG features were associated with age and were independently coincident with clinical factors relating to higher cardiovascular risks. Parameters, especially the McPhie score and Gubner & Ungerleider criterion, identified ventricular hypertrophy well in subjects less than 65 years old. Similar to the previous findings in our study, various ECG parameters seemed to be less reliable in identifying both cardiovascular risks in the elderly population. The reasons can be 2efold. As the ventricular remodeling process, assessed by various surface ECG parameters, may actually denote ventricular hypertrophy in terms of extremely increased LV mass, recent studies indicated that the main cardiac phenotype alterations relating to various cardiovascular risk factors in elderly subjects may actually involve concentric remodeling 26 . Such concentric remodeling processes and alterations may not necessarily be characterized by surface ECG parameters. Furthermore, the potential selection bias in this study may also help to explain this finding. As a hypertrophied heart structure and higher cardiovascular risk score reflecting underlying metabolic derangements may denote supplemental pathways into higher cardiovascular risks, subjects carrying on both features may theoretically experience higher events and less possibly survive longer, which may thus attenuate the correlation between each other in the elderly population 26 .
Conclusion
We have shown that electrical alterations, as determined by the Gubner & Ungerleider criteria and McPhie scores obtained from 12-lead surface ECG, were correlated with age and estimated cardiovascular risk factors. Furthermore, Cornell Product and gender-adjusted Cornell criteria further identified well the ventricular structural changes associated with LVH in the younger Fig. 2 . ROC curve for predicting LVH in participants who were younger or older than 65 years of age. population. However, surface ECG may be less reliable in the older population. Our results suggested that quantitative electrocardiography may be clinically feasible and they were highly associated with several cardiovascular risk surrogates.
